TrialClinical pharmacokinetics2008

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

Wolfgang Mueck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.